nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitrofurantoin—ABCG2—Vemurafenib—melanoma	0.414	0.498	CbGbCtD
Nitrofurantoin—ABCG2—Dactinomycin—melanoma	0.275	0.331	CbGbCtD
Nitrofurantoin—ABCG2—Docetaxel—melanoma	0.142	0.171	CbGbCtD
Nitrofurantoin—Fibrosis—Carmustine—melanoma	0.00588	0.0347	CcSEcCtD
Nitrofurantoin—Lung infiltration—Bleomycin—melanoma	0.0041	0.0242	CcSEcCtD
Nitrofurantoin—Lung infiltration—Carmustine—melanoma	0.00358	0.0212	CcSEcCtD
Nitrofurantoin—Interstitial pneumonia—Temozolomide—melanoma	0.00336	0.0198	CcSEcCtD
Nitrofurantoin—Polyneuropathy—Docetaxel—melanoma	0.00331	0.0196	CcSEcCtD
Nitrofurantoin—Vasculitis—Vemurafenib—melanoma	0.00326	0.0192	CcSEcCtD
Nitrofurantoin—Reaction gastrointestinal—Docetaxel—melanoma	0.00323	0.0191	CcSEcCtD
Nitrofurantoin—Eruption—Dactinomycin—melanoma	0.00292	0.0172	CcSEcCtD
Nitrofurantoin—Interstitial lung disease—Bleomycin—melanoma	0.00272	0.0161	CcSEcCtD
Nitrofurantoin—Interstitial lung disease—Carmustine—melanoma	0.00237	0.014	CcSEcCtD
Nitrofurantoin—Interstitial lung disease—Temozolomide—melanoma	0.00229	0.0135	CcSEcCtD
Nitrofurantoin—Interstitial pneumonia—Docetaxel—melanoma	0.00223	0.0132	CcSEcCtD
Nitrofurantoin—Eosinophilia—Vemurafenib—melanoma	0.00197	0.0116	CcSEcCtD
Nitrofurantoin—Stevens-Johnson syndrome—Vemurafenib—melanoma	0.00176	0.0104	CcSEcCtD
Nitrofurantoin—Eruption—Docetaxel—melanoma	0.00176	0.0104	CcSEcCtD
Nitrofurantoin—Neuropathy peripheral—Vemurafenib—melanoma	0.00174	0.0103	CcSEcCtD
Nitrofurantoin—Aplastic anaemia—Dactinomycin—melanoma	0.00169	0.00995	CcSEcCtD
Nitrofurantoin—Liver disorder—Docetaxel—melanoma	0.00158	0.00935	CcSEcCtD
Nitrofurantoin—Haemoglobin decreased—Docetaxel—melanoma	0.00157	0.00926	CcSEcCtD
Nitrofurantoin—Interstitial lung disease—Docetaxel—melanoma	0.00153	0.00901	CcSEcCtD
Nitrofurantoin—Aplastic anaemia—Temozolomide—melanoma	0.00152	0.009	CcSEcCtD
Nitrofurantoin—Erythema multiforme—Vemurafenib—melanoma	0.00151	0.0089	CcSEcCtD
Nitrofurantoin—Chills—Vemurafenib—melanoma	0.00143	0.00845	CcSEcCtD
Nitrofurantoin—Pleural effusion—Docetaxel—melanoma	0.00141	0.00832	CcSEcCtD
Nitrofurantoin—Alopecia—Vemurafenib—melanoma	0.00141	0.00832	CcSEcCtD
Nitrofurantoin—Diabetes mellitus—Carmustine—melanoma	0.0014	0.00828	CcSEcCtD
Nitrofurantoin—Dermatitis exfoliative—Temozolomide—melanoma	0.00125	0.00737	CcSEcCtD
Nitrofurantoin—Cough—Vemurafenib—melanoma	0.00121	0.00715	CcSEcCtD
Nitrofurantoin—Myalgia—Vemurafenib—melanoma	0.00118	0.00698	CcSEcCtD
Nitrofurantoin—Aspartate aminotransferase increased—Dactinomycin—melanoma	0.00117	0.00693	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Vemurafenib—melanoma	0.00113	0.00669	CcSEcCtD
Nitrofurantoin—Aspartate aminotransferase increased—Temozolomide—melanoma	0.00106	0.00626	CcSEcCtD
Nitrofurantoin—Alanine aminotransferase increased—Temozolomide—melanoma	0.00104	0.00614	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00103	0.0061	CcSEcCtD
Nitrofurantoin—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.000996	0.00588	CcSEcCtD
Nitrofurantoin—Decreased appetite—Vemurafenib—melanoma	0.000985	0.00582	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Vemurafenib—melanoma	0.000979	0.00578	CcSEcCtD
Nitrofurantoin—Constipation—Vemurafenib—melanoma	0.000969	0.00572	CcSEcCtD
Nitrofurantoin—Hypoaesthesia—Bleomycin—melanoma	0.000962	0.00568	CcSEcCtD
Nitrofurantoin—Agranulocytosis—Dactinomycin—melanoma	0.000937	0.00553	CcSEcCtD
Nitrofurantoin—Renal failure—Carmustine—melanoma	0.000924	0.00545	CcSEcCtD
Nitrofurantoin—Neuropathy peripheral—Carmustine—melanoma	0.000921	0.00544	CcSEcCtD
Nitrofurantoin—Hepatitis—Dactinomycin—melanoma	0.000901	0.00532	CcSEcCtD
Nitrofurantoin—Stevens-Johnson syndrome—Temozolomide—melanoma	0.0009	0.00532	CcSEcCtD
Nitrofurantoin—Body temperature increased—Vemurafenib—melanoma	0.000896	0.00529	CcSEcCtD
Nitrofurantoin—Neuropathy peripheral—Temozolomide—melanoma	0.00089	0.00526	CcSEcCtD
Nitrofurantoin—Chills—Bleomycin—melanoma	0.000867	0.00512	CcSEcCtD
Nitrofurantoin—Alopecia—Bleomycin—melanoma	0.000854	0.00504	CcSEcCtD
Nitrofurantoin—Erythema multiforme—Dactinomycin—melanoma	0.000852	0.00503	CcSEcCtD
Nitrofurantoin—Hypoaesthesia—Carmustine—melanoma	0.000839	0.00496	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Vemurafenib—melanoma	0.000835	0.00493	CcSEcCtD
Nitrofurantoin—Renal impairment—Docetaxel—melanoma	0.000824	0.00486	CcSEcCtD
Nitrofurantoin—Hepatitis—Temozolomide—melanoma	0.000815	0.00481	CcSEcCtD
Nitrofurantoin—Asthenia—Vemurafenib—melanoma	0.000813	0.0048	CcSEcCtD
Nitrofurantoin—Hypoaesthesia—Temozolomide—melanoma	0.000811	0.00479	CcSEcCtD
Nitrofurantoin—Chills—Dactinomycin—melanoma	0.000809	0.00477	CcSEcCtD
Nitrofurantoin—Alopecia—Dactinomycin—melanoma	0.000797	0.0047	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Bleomycin—melanoma	0.000781	0.00461	CcSEcCtD
Nitrofurantoin—Anaemia—Bleomycin—melanoma	0.000778	0.00459	CcSEcCtD
Nitrofurantoin—Diarrhoea—Vemurafenib—melanoma	0.000776	0.00458	CcSEcCtD
Nitrofurantoin—Erythema multiforme—Temozolomide—melanoma	0.000771	0.00455	CcSEcCtD
Nitrofurantoin—Malaise—Bleomycin—melanoma	0.000759	0.00448	CcSEcCtD
Nitrofurantoin—Leukopenia—Bleomycin—melanoma	0.000753	0.00445	CcSEcCtD
Nitrofurantoin—Dizziness—Vemurafenib—melanoma	0.00075	0.00442	CcSEcCtD
Nitrofurantoin—Alopecia—Carmustine—melanoma	0.000746	0.0044	CcSEcCtD
Nitrofurantoin—Cough—Bleomycin—melanoma	0.000734	0.00433	CcSEcCtD
Nitrofurantoin—Chills—Temozolomide—melanoma	0.000732	0.00432	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Dactinomycin—melanoma	0.000728	0.0043	CcSEcCtD
Nitrofurantoin—Anaemia—Dactinomycin—melanoma	0.000725	0.00428	CcSEcCtD
Nitrofurantoin—Vomiting—Vemurafenib—melanoma	0.000721	0.00425	CcSEcCtD
Nitrofurantoin—Alopecia—Temozolomide—melanoma	0.00072	0.00425	CcSEcCtD
Nitrofurantoin—Chest pain—Bleomycin—melanoma	0.000716	0.00423	CcSEcCtD
Nitrofurantoin—Myalgia—Bleomycin—melanoma	0.000716	0.00423	CcSEcCtD
Nitrofurantoin—Rash—Vemurafenib—melanoma	0.000715	0.00422	CcSEcCtD
Nitrofurantoin—Headache—Vemurafenib—melanoma	0.00071	0.00419	CcSEcCtD
Nitrofurantoin—Discomfort—Bleomycin—melanoma	0.000708	0.00418	CcSEcCtD
Nitrofurantoin—Malaise—Dactinomycin—melanoma	0.000708	0.00418	CcSEcCtD
Nitrofurantoin—Aspartate aminotransferase increased—Docetaxel—melanoma	0.000706	0.00417	CcSEcCtD
Nitrofurantoin—Leukopenia—Dactinomycin—melanoma	0.000702	0.00415	CcSEcCtD
Nitrofurantoin—Confusional state—Bleomycin—melanoma	0.000692	0.00409	CcSEcCtD
Nitrofurantoin—Alanine aminotransferase increased—Docetaxel—melanoma	0.000691	0.00408	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Bleomycin—melanoma	0.000687	0.00405	CcSEcCtD
Nitrofurantoin—Anaemia—Carmustine—melanoma	0.000679	0.00401	CcSEcCtD
Nitrofurantoin—Nausea—Vemurafenib—melanoma	0.000673	0.00397	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Bleomycin—melanoma	0.000672	0.00397	CcSEcCtD
Nitrofurantoin—Myalgia—Dactinomycin—melanoma	0.000668	0.00394	CcSEcCtD
Nitrofurantoin—Discomfort—Dactinomycin—melanoma	0.00066	0.0039	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Temozolomide—melanoma	0.000659	0.00389	CcSEcCtD
Nitrofurantoin—Leukopenia—Carmustine—melanoma	0.000657	0.00388	CcSEcCtD
Nitrofurantoin—Anaemia—Temozolomide—melanoma	0.000656	0.00387	CcSEcCtD
Nitrofurantoin—Anorexia—Bleomycin—melanoma	0.000655	0.00386	CcSEcCtD
Nitrofurantoin—Malaise—Temozolomide—melanoma	0.00064	0.00378	CcSEcCtD
Nitrofurantoin—Vertigo—Temozolomide—melanoma	0.000638	0.00376	CcSEcCtD
Nitrofurantoin—Leukopenia—Temozolomide—melanoma	0.000635	0.00375	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Dactinomycin—melanoma	0.000627	0.0037	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Bleomycin—melanoma	0.000626	0.00369	CcSEcCtD
Nitrofurantoin—Myalgia—Carmustine—melanoma	0.000625	0.00369	CcSEcCtD
Nitrofurantoin—Chest pain—Carmustine—melanoma	0.000625	0.00369	CcSEcCtD
Nitrofurantoin—Cough—Temozolomide—melanoma	0.000619	0.00366	CcSEcCtD
Nitrofurantoin—Paraesthesia—Bleomycin—melanoma	0.000617	0.00364	CcSEcCtD
Nitrofurantoin—Dyspnoea—Bleomycin—melanoma	0.000612	0.00361	CcSEcCtD
Nitrofurantoin—Anorexia—Dactinomycin—melanoma	0.00061	0.0036	CcSEcCtD
Nitrofurantoin—Confusional state—Carmustine—melanoma	0.000604	0.00357	CcSEcCtD
Nitrofurantoin—Myalgia—Temozolomide—melanoma	0.000604	0.00357	CcSEcCtD
Nitrofurantoin—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000599	0.00353	CcSEcCtD
Nitrofurantoin—Discomfort—Temozolomide—melanoma	0.000597	0.00352	CcSEcCtD
Nitrofurantoin—Decreased appetite—Bleomycin—melanoma	0.000597	0.00352	CcSEcCtD
Nitrofurantoin—Renal failure—Docetaxel—melanoma	0.000594	0.0035	CcSEcCtD
Nitrofurantoin—Neuropathy peripheral—Docetaxel—melanoma	0.000592	0.00349	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Carmustine—melanoma	0.000587	0.00346	CcSEcCtD
Nitrofurantoin—Confusional state—Temozolomide—melanoma	0.000584	0.00345	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000584	0.00344	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Temozolomide—melanoma	0.000579	0.00342	CcSEcCtD
Nitrofurantoin—Anorexia—Carmustine—melanoma	0.000571	0.00337	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Temozolomide—melanoma	0.000567	0.00335	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Bleomycin—melanoma	0.000566	0.00334	CcSEcCtD
Nitrofurantoin—Agranulocytosis—Docetaxel—melanoma	0.000564	0.00333	CcSEcCtD
Nitrofurantoin—Decreased appetite—Dactinomycin—melanoma	0.000557	0.00329	CcSEcCtD
Nitrofurantoin—Anorexia—Temozolomide—melanoma	0.000552	0.00326	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Carmustine—melanoma	0.000546	0.00322	CcSEcCtD
Nitrofurantoin—Body temperature increased—Bleomycin—melanoma	0.000543	0.0032	CcSEcCtD
Nitrofurantoin—Hepatitis—Docetaxel—melanoma	0.000542	0.0032	CcSEcCtD
Nitrofurantoin—Hypoaesthesia—Docetaxel—melanoma	0.00054	0.00318	CcSEcCtD
Nitrofurantoin—Paraesthesia—Carmustine—melanoma	0.000538	0.00318	CcSEcCtD
Nitrofurantoin—Dyspnoea—Carmustine—melanoma	0.000534	0.00315	CcSEcCtD
Nitrofurantoin—Somnolence—Carmustine—melanoma	0.000533	0.00315	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Dactinomycin—melanoma	0.000528	0.00312	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Temozolomide—melanoma	0.000528	0.00312	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Dactinomycin—melanoma	0.000524	0.00309	CcSEcCtD
Nitrofurantoin—Decreased appetite—Carmustine—melanoma	0.000521	0.00308	CcSEcCtD
Nitrofurantoin—Paraesthesia—Temozolomide—melanoma	0.00052	0.00307	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Carmustine—melanoma	0.000518	0.00305	CcSEcCtD
Nitrofurantoin—Dyspnoea—Temozolomide—melanoma	0.000516	0.00305	CcSEcCtD
Nitrofurantoin—Somnolence—Temozolomide—melanoma	0.000515	0.00304	CcSEcCtD
Nitrofurantoin—Erythema multiforme—Docetaxel—melanoma	0.000513	0.00303	CcSEcCtD
Nitrofurantoin—Constipation—Carmustine—melanoma	0.000513	0.00303	CcSEcCtD
Nitrofurantoin—Dyspepsia—Temozolomide—melanoma	0.00051	0.00301	CcSEcCtD
Nitrofurantoin—Body temperature increased—Dactinomycin—melanoma	0.000506	0.00299	CcSEcCtD
Nitrofurantoin—Abdominal pain—Dactinomycin—melanoma	0.000506	0.00299	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Bleomycin—melanoma	0.000506	0.00299	CcSEcCtD
Nitrofurantoin—Decreased appetite—Temozolomide—melanoma	0.000504	0.00297	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Temozolomide—melanoma	0.0005	0.00295	CcSEcCtD
Nitrofurantoin—Constipation—Temozolomide—melanoma	0.000495	0.00292	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Carmustine—melanoma	0.000494	0.00292	CcSEcCtD
Nitrofurantoin—Asthenia—Bleomycin—melanoma	0.000493	0.00291	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Carmustine—melanoma	0.00049	0.00289	CcSEcCtD
Nitrofurantoin—Chills—Docetaxel—melanoma	0.000487	0.00287	CcSEcCtD
Nitrofurantoin—Alopecia—Docetaxel—melanoma	0.000479	0.00283	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Temozolomide—melanoma	0.000477	0.00282	CcSEcCtD
Nitrofurantoin—Body temperature increased—Carmustine—melanoma	0.000474	0.0028	CcSEcCtD
Nitrofurantoin—Abdominal pain—Carmustine—melanoma	0.000474	0.0028	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Temozolomide—melanoma	0.000474	0.0028	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Dactinomycin—melanoma	0.000472	0.00279	CcSEcCtD
Nitrofurantoin—Asthenia—Dactinomycin—melanoma	0.00046	0.00271	CcSEcCtD
Nitrofurantoin—Body temperature increased—Temozolomide—melanoma	0.000458	0.0027	CcSEcCtD
Nitrofurantoin—Abdominal pain—Temozolomide—melanoma	0.000458	0.0027	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Carmustine—melanoma	0.000442	0.00261	CcSEcCtD
Nitrofurantoin—Diarrhoea—Dactinomycin—melanoma	0.000438	0.00259	CcSEcCtD
Nitrofurantoin—Vomiting—Bleomycin—melanoma	0.000437	0.00258	CcSEcCtD
Nitrofurantoin—Anaemia—Docetaxel—melanoma	0.000436	0.00258	CcSEcCtD
Nitrofurantoin—Rash—Bleomycin—melanoma	0.000433	0.00256	CcSEcCtD
Nitrofurantoin—Asthenia—Carmustine—melanoma	0.00043	0.00254	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Temozolomide—melanoma	0.000427	0.00252	CcSEcCtD
Nitrofurantoin—Leukopenia—Docetaxel—melanoma	0.000423	0.00249	CcSEcCtD
Nitrofurantoin—Asthenia—Temozolomide—melanoma	0.000416	0.00245	CcSEcCtD
Nitrofurantoin—Cough—Docetaxel—melanoma	0.000412	0.00243	CcSEcCtD
Nitrofurantoin—Diarrhoea—Carmustine—melanoma	0.00041	0.00242	CcSEcCtD
Nitrofurantoin—Nausea—Bleomycin—melanoma	0.000408	0.00241	CcSEcCtD
Nitrofurantoin—Vomiting—Dactinomycin—melanoma	0.000407	0.0024	CcSEcCtD
Nitrofurantoin—Rash—Dactinomycin—melanoma	0.000404	0.00238	CcSEcCtD
Nitrofurantoin—Chest pain—Docetaxel—melanoma	0.000402	0.00237	CcSEcCtD
Nitrofurantoin—Myalgia—Docetaxel—melanoma	0.000402	0.00237	CcSEcCtD
Nitrofurantoin—Dizziness—Carmustine—melanoma	0.000396	0.00234	CcSEcCtD
Nitrofurantoin—Diarrhoea—Temozolomide—melanoma	0.000396	0.00234	CcSEcCtD
Nitrofurantoin—Confusional state—Docetaxel—melanoma	0.000388	0.00229	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Docetaxel—melanoma	0.000385	0.00227	CcSEcCtD
Nitrofurantoin—Dizziness—Temozolomide—melanoma	0.000383	0.00226	CcSEcCtD
Nitrofurantoin—Vomiting—Carmustine—melanoma	0.000381	0.00225	CcSEcCtD
Nitrofurantoin—Nausea—Dactinomycin—melanoma	0.00038	0.00225	CcSEcCtD
Nitrofurantoin—Rash—Carmustine—melanoma	0.000378	0.00223	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Docetaxel—melanoma	0.000377	0.00223	CcSEcCtD
Nitrofurantoin—Headache—Carmustine—melanoma	0.000376	0.00222	CcSEcCtD
Nitrofurantoin—Vomiting—Temozolomide—melanoma	0.000368	0.00217	CcSEcCtD
Nitrofurantoin—Anorexia—Docetaxel—melanoma	0.000367	0.00217	CcSEcCtD
Nitrofurantoin—Rash—Temozolomide—melanoma	0.000365	0.00216	CcSEcCtD
Nitrofurantoin—Headache—Temozolomide—melanoma	0.000363	0.00214	CcSEcCtD
Nitrofurantoin—Nausea—Carmustine—melanoma	0.000356	0.0021	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Docetaxel—melanoma	0.000351	0.00207	CcSEcCtD
Nitrofurantoin—Paraesthesia—Docetaxel—melanoma	0.000346	0.00204	CcSEcCtD
Nitrofurantoin—Nausea—Temozolomide—melanoma	0.000344	0.00203	CcSEcCtD
Nitrofurantoin—Dyspnoea—Docetaxel—melanoma	0.000343	0.00203	CcSEcCtD
Nitrofurantoin—Somnolence—Docetaxel—melanoma	0.000342	0.00202	CcSEcCtD
Nitrofurantoin—Dyspepsia—Docetaxel—melanoma	0.000339	0.002	CcSEcCtD
Nitrofurantoin—Decreased appetite—Docetaxel—melanoma	0.000335	0.00198	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Docetaxel—melanoma	0.000333	0.00196	CcSEcCtD
Nitrofurantoin—Constipation—Docetaxel—melanoma	0.000329	0.00194	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Docetaxel—melanoma	0.000317	0.00187	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Docetaxel—melanoma	0.000315	0.00186	CcSEcCtD
Nitrofurantoin—Body temperature increased—Docetaxel—melanoma	0.000305	0.0018	CcSEcCtD
Nitrofurantoin—Abdominal pain—Docetaxel—melanoma	0.000305	0.0018	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Docetaxel—melanoma	0.000284	0.00168	CcSEcCtD
Nitrofurantoin—Asthenia—Docetaxel—melanoma	0.000276	0.00163	CcSEcCtD
Nitrofurantoin—Diarrhoea—Docetaxel—melanoma	0.000264	0.00156	CcSEcCtD
Nitrofurantoin—Dizziness—Docetaxel—melanoma	0.000255	0.0015	CcSEcCtD
Nitrofurantoin—Vomiting—Docetaxel—melanoma	0.000245	0.00145	CcSEcCtD
Nitrofurantoin—Rash—Docetaxel—melanoma	0.000243	0.00143	CcSEcCtD
Nitrofurantoin—Headache—Docetaxel—melanoma	0.000241	0.00142	CcSEcCtD
Nitrofurantoin—Nausea—Docetaxel—melanoma	0.000229	0.00135	CcSEcCtD
